Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery

J Auton Pharmacol. 1999 Jun;19(3):145-9. doi: 10.1046/j.1365-2680.1999.00128.x.

Abstract

1. The properties of beta-adrenoceptors mediating vascular relaxation in rat isolated carotid artery were investigated. Ring segments of arteries were preconstricted with the thromboxane A2 receptor agonist U-46619 and relaxation to beta-adrenoceptor agonists determined. 2. Isoprenaline produced a concentration-dependent relaxation of U-44619-constricted arteries. The concentration-response curve (CRC) to isoprenaline was shifted to the right by propranolol (1 microM) although the shift was less (105 fold; pA2, 8.02) than would be expected for an effect of isoprenaline at classical beta-adrenoceptors (300-1000 fold; pA2, 8.5-9). L-NAME (100 microM) significantly reduced responses to isoprenaline, lowering the slope of the CRC and reducing the maximum response. 3. The selective beta3-adrenoceptor agonists, BRL 37344 and ZD2079, also produced concentration-dependent relaxation of the arteries. L-NAME (100 microM) shifted the BRL 37344 CRC to the right 15 fold with no reduction in the slope or maximum response. L-NAME (100 microM) had no significant effect on the ZD2079 CRC. 4. In conclusion, relaxation to isoprenaline in rat carotid artery is inhibited by propranolol in a manner suggesting a mixed population of classical (beta1-/beta2-) and atypical (beta3-) adrenoceptors. The presence of beta3-adrenoceptors was confirmed by the relaxant effects of the selective beta3-adrenoceptor agonists BRL 37344 and ZD2079. L-NAME attenuated responses to both isoprenaline and the beta3-adrenoceptor agonist BRL 37344, suggesting a role for endothelial release of nitric oxide in beta-adrenoceptor mediated relaxation. However, the relaxant effect of BRL 37344 was attenuated by L-NAME to a lesser extent than that of isoprenaline. In addition, L-NAME had no effect on relaxation induced by ZD2079. These results suggest that there may be a differential contribution of endothelium to classical beta-and beta3-adrenoceptor-mediated effects, with endothelium contributing less to beta3-adrenoceptor-mediated relaxation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Carotid Artery, Common / drug effects
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Ethanolamines / pharmacology
  • In Vitro Techniques
  • Isoproterenol / pharmacology
  • Male
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology*
  • Phenylacetates / pharmacology
  • Propranolol / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta / physiology*
  • Thromboxane A2 / pharmacology
  • Vasoconstrictor Agents / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Ethanolamines
  • Phenylacetates
  • Receptors, Adrenergic, beta
  • Vasoconstrictor Agents
  • Thromboxane A2
  • BRL 37344
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Propranolol
  • Isoproterenol
  • talibegron hydrochloride
  • NG-Nitroarginine Methyl Ester